Skip to main content

Part of the book series: Lecture Notes in Computer Science ((LNIP,volume 6367))

Included in the following conference series:

  • 824 Accesses

Abstract

With a total of 192,280 new cases predicted for 2009, prostate cancer (PC) now accounts for 25% of all new male cancers diagnosed in the United States [1]. Furthermore, in their lifetime, one in six men will be clinically diagnosed with having PC, although many more men are found to have histological evidence of PC at autopsy [2,3,4]. Presently, approximately 1 in 10 men will die of PC [5,6]. The ever-aging population and wider spread use of the blood prostate-specific antigen (PSA) test [7,8], as well as the tendency to apply lower cut-off levels for this test [9], will further increase the diagnosis of this disease [10].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Thun, M.J.: Cancer Statistics, 2009. CA Cancer J. Clin. 59(4), 225–249 (2009)

    Article  Google Scholar 

  2. Carter, H.B., Piantadosi, S., Isaacs, J.T.: Clinical evidence for and implications of the multistep development of prostate cancer. J. Urol. 143(4), 742–746 (1990)

    Google Scholar 

  3. Parkin, D.M., Bray, F.I., Devesa, S.S.: Cancer burden in the year 2000. the global picture. Eur J Cancer 37(suppl. 8), S4–S66 (2001)

    Article  Google Scholar 

  4. Konety, B., Bird, V., Deorah, S., Dahmoush, L.: Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era. The Journal of Urology 174(5), 1785–1788 (2005)

    Article  Google Scholar 

  5. Crawford, E.D.: Epidemiology of prostate cancer. Urology 62(6 suppl. 1), 3–12 (2003)

    Article  Google Scholar 

  6. Stewart, S.L., King, J.B., Thompson, T.D., Friedman, C., Wingo, P.A.: Cancer mortality surveillance–united states, 1990-2000. MMWR Surveill Summ 53(3), 1–108 (2004)

    Google Scholar 

  7. Catalona, W.J., Loeb, S., Han, M.: Viewpoint: expanding prostate cancer screening. Ann. Intern. Med. 144(6), 441–443 (2006)

    Google Scholar 

  8. Hoffman, R.M.: Viewpoint: limiting prostate cancer screening. Ann. Intern. Med. 144(6), 438–440 (2006)

    Google Scholar 

  9. Graif, T., Loeb, S., Roehl, K.A., Gashti, S.N., Griffin, C., Yu, X., Catalona, W.J.: Under diagnosis and over diagnosis of prostate cancer. J. Urol. 178(1), 88–92 (2007)

    Article  Google Scholar 

  10. Max, W., Rice, D.P., Sung, H.Y., Michel, M., Breuer, W., Zhang, X.: The economic burden of prostate cancer, california, 1998. Cancer 94(11), 2906–2913 (2002)

    Article  Google Scholar 

  11. Mangar, S.A., Huddart, R.A., Parker, C.C., Dearnaley, D.P., Khoo, V.S., Horwich, A.: Technological advances in radiotherapy for the treatment of localised prostate cancer. Eur. J. cancer 41(6), 908–921 (2005)

    Article  Google Scholar 

  12. Meraney, A.M., Haese, A., Palisaar, J., Graefen, M., Steuber, T., Huland, H., Klein, E.A.: Surgical management of prostate cancer: advances based on a rational approach to the data. Eur. J. Cancer 41(6), 888–907 (2005)

    Article  Google Scholar 

  13. Bucci, M.K., Bevan, A., Roach III, M.: Advances in radiation therapy: conventional to 3d, to imrt, to 4d, and beyond. CA Cancer J. Clin. 55(2), 117–134 (2005)

    Article  Google Scholar 

  14. Hricak, H., Wang, L., Wei, D.C., Coakley, F.V., Akin, O., Reuter, V.E., Gonen, M., Kattan, M.W., Onyebuchi, C.N., Scardino, P.T.: The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy. Cancer 100(12), 2655–2663 (2004)

    Article  Google Scholar 

  15. Cellini, N., Morganti, A.G., Mattiucci, G.C., Valentini, V., Leone, M., Luzi, S., Manfredi, R., Dinapoli, N., Digesu, C., Smaniotto, D.: Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: implications for conformal therapy planning. Int. J. Radiat. Oncol. Biol. Phys. 53(3), 595–599 (2002)

    Article  Google Scholar 

  16. Roach, M.: Reducing the toxicity associated with the use of radiotherapy in men with localized prostate cancer. Urologic Clinics of North America 31(2), 353–366 (2004)

    Article  Google Scholar 

  17. Baxter, N.N., Tepper, J.E., Durham, S.B., Rothenberger, D.A., Virnig, B.A.: Increased risk of rectal cancer after prostate radiation: a population-based study. Gastroenterology 128(4), 819–824 (2005)

    Article  Google Scholar 

  18. Steyn, J.H., Smith, F.W.: Nuclear magnetic resonance imaging of the prostate. Br. J. Urol. 54(6), 726–728 (1982)

    Article  Google Scholar 

  19. Hricak, H., Williams, R.D., Spring, D.B., Moon Jr., K.L., Hedgcock, M.W., Watson, R.A., Crooks, L.E.: Anatomy and pathology of the male pelvis by magnetic resonance imaging. AJR Am. J. Roentgenol. 141(6), 1101–1110 (1983)

    Google Scholar 

  20. Villeirs, G.M., Oosterlinck, W., Vanherreweghe, E., De Meerleer, G.O.: A qualitative approach to combined magnetic resonance imaging and spectroscopy in the diagnosis of prostate cancer. Eur. J. Radiol. 73(2), 352–356 (2010)

    Article  Google Scholar 

  21. Tanimoto, A., Nakashima, J., Kohno, H., Shinmoto, H., Kuribayashi, S.: Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic mr imaging in combination with t2-weighted imaging. J. Magn. Reson. Imaging 25(1), 146–152 (2007)

    Article  Google Scholar 

  22. Scheenen, T.W., Klomp, D.W., Roll, S.A., Futterer, J.J., Barentsz, J.O., Heerschap, A.: Fast acquisition-weighted three-dimensional proton mr spectroscopic imaging of the human prostate. Magn. Reson. Med. 52(1), 80–88 (2004)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Fütterer, J.J. (2010). Prostate Cancer MR Imaging. In: Madabhushi, A., Dowling, J., Yan, P., Fenster, A., Abolmaesumi, P., Hata, N. (eds) Prostate Cancer Imaging. Computer-Aided Diagnosis, Prognosis, and Intervention. Prostate Cancer Imaging 2010. Lecture Notes in Computer Science, vol 6367. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-15989-3_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-15989-3_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-15988-6

  • Online ISBN: 978-3-642-15989-3

  • eBook Packages: Computer ScienceComputer Science (R0)

Publish with us

Policies and ethics